Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient

Leukemia and Lymphoma

Volumn 26, Issue 1-2, 1997, Pages 205-207

  Mahon, François Xavier ^a   Nabera, Christelle Bilhou ^b   Pellegrin, Jean Luc ^c   Cony Makhoul, Pascale ^d   Leng, Bernard ^c   Bernard, Philippe ^b   Reiffers, Josy ^a,d  

^a CNRS Bordeaux Segalen University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Hopital Haut Levêque ^*

^d HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Chronic myelogenous leukemia; Interferon alpha; Zidovudine

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; GENE REARRANGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MALE; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REMISSION;

EID: 8544259576     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709109178     Document Type: Article

References (9)

1. Talpaz, M., Kantarjian, H., Kurzrock, R., Trujillo, J. M. and Gutterman, J. U. (1991). Interferon-Alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome positive patients. Annals of Internal Medicine, 114, 532-538.
2. Estro, Z., Talpaz, M., Chou, T. C., Kurzrock, R., Blake, M. and Gutterman, J U. (1991). Synergistic antiproliferative effect of Interferon alpha and azidothymidine in chronic myelogenous leukemia, Leukemia, 5, 101-107.
3. Sokal, J. E., Cox, E. B., Baccarani, M., Tura, S., Gomez, G A., Robertson, J., Tso, C Y., Braun, T. J., Clarkson, B. D., Cerventes, F., Rozman, C. and the Italian Cooperative CML Study Group. (1984). Prognostic discrimination in "good-risk" chronic granulocytic leukemia, Blood, 63, 789-799.
4. Malinge, M C., Mahon, F X., Delfau, M. H., Daheron, L., Kitzis, A., Guilhot, F., Tanzer, J. and Grandchamp, B. (1992). Quantitative determination of the hybrid bcr-abl mRNA in patients with chronic myelogenous leukemia under interferon therapy. British Journal of Haematology, 82, 701-707
5. Berman, E., Duigou-Osterdorf, R., Known, S. E., Fanuccht, M. P., Chou, J., Hirsch, M. S., Clarkson, B. D. and Chou, T. C. (1989). Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells, Blood, 74, 1281-1286.
6. Strayer, D. R. Brodsky, I., Caranfa, M. J. and Gillespie, D. H. (1982). Quantitation of RNA-dependent DNA polymerase in patients with myeloproliferative disorders, British Journal of Haematology, 50, 521-530.
7. Robak, T., Korycka, A. and Gora-Tybor, J (1994). The interaction of 2-chlorodeoxyadenosine (2+ CDA) and interferon-α (IFN-α) on normal and myeloid leukemia hematopoiesis in vitro, Leukemia Research, 18, 275-281.
8. Osman, Y., Moriyama, Y. and Shibata, A (1995). Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-α, TNF, and quercetin): its application to autologous bone marrow transplantation for CML, Experimental Hematology, 2, 344-452.
9. Gallo, R. C. (1995). A surprising advance in the treatment of viral leukemia, New England Journal of Medicine, 332, 1783-1785